Fertility Tourism Market Size & Growth Forecast 2027–2036, By Segments (Age Group, Treatment, Country), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Fertility Tourism Market size was assessed at USD 2.6 billion in 2026 and is poised to grow at a 23.85% CAGR between 2027 and 2036, surpassing USD 22.08 billion by 2036. The industry revenue for 2027 is estimated at USD 3.12 billion.
Get more details on this report
Request Free Sample ReportFertility Tourism Market Intelligence Snapshot
Regional Market Dynamics
- Europe leads due to a strong network of fertility clinics, advanced reproductive treatments, and established cross-border patient flows seeking diverse procedures and reduced waiting times across the region.
- Asia Pacific is growing at 26.84% CAGR driven by affordable treatment options, expanding fertility centers, improved clinical capabilities, and increasing international patient flows through structured medical travel services.
Segment Momentum
- The 35–44 age group accounted for 44.57% of the market in 2026 because patients increasingly travel abroad for timely access to specialized, cost-effective fertility treatments while remaining broadly eligible for assisted reproduction.
- Donor Egg Treatment is the fastest-growing segment as patients seek international access to donor programs when domestic availability, regulations, or treatment costs limit conventional fertility options.
Market Expansion Drivers
- Rising infertility prevalence increasing cross-border demand for IVF and reproductive treatment services.
- Expansion of advanced IVF clinics and ART infrastructure improving international patient accessibility.
- Growing fertility financing and treatment affordability programs supporting medical travel adoption.
Leading Market Participants
- Leading companies in the fertility tourism market include Bumrungrad International Hospital (Thailand), Apollo Fertility (India), Barcelona IVF (Spain), IVF-Life Group (Spain), Alpha IVF & Women’s Specialists (Malaysia), Manchester Fertility Services Ltd. (United Kingdom), San Diego Fertility Center (United States), Eva Fertility Clinics (Cyprus), Genesis IVF Centre (India).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.6 billion
- 2027 Estimated Market Size: USD 3.12 billion.
- Projected Market Size: USD 22.08 billion by 2036
- Growth Forecast: 23.85% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: Europe
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: 35-44 (Age Group) | IVF With Own Egg (Treatment) | Turkey (Country)
- Emerging Opportunity Segment: 45-54 (Age Group) | Donor Egg Treatment (Treatment) | Spain (Country)
Market Growth Drivers and Industry Trends
Rising infertility prevalence increasing cross-border demand for IVF and reproductive treatment services
Increasing infertility concerns are encouraging individuals and couples to explore treatment options beyond their home countries, which will drive the fertility tourism market growth through greater demand for cross-border reproductive care. Differences in treatment availability, regulatory frameworks, waiting periods, and costs can influence patients when selecting international destinations for assisted reproductive procedures such as in vitro fertilization. International treatment can also provide access to specialized reproductive techniques or clinical expertise that may not be readily available in a patient's domestic healthcare system. As more patients seek timely and suitable fertility interventions, medical travel is becoming an important pathway for accessing reproductive treatment services.
Expansion of advanced IVF clinics and ART infrastructure improving international patient accessibility
The development of specialized fertility clinics and assisted reproductive technology infrastructure is making treatment destinations more capable of serving patients from overseas, thereby strengthening the fertility tourism market. Modern IVF facilities with advanced laboratory capabilities can provide a broader range of reproductive procedures, while experienced clinical teams and integrated patient services can simplify treatment for international visitors. Improvements in laboratory processes, fertility diagnostics, embryo management, and treatment coordination also support greater confidence among patients considering care abroad. The availability of specialized infrastructure across established and emerging fertility destinations expands the range of locations where international patients can pursue assisted reproductive treatment.
Growing fertility financing and treatment affordability programs supporting medical travel adoption
The availability of financing arrangements and affordability-focused fertility programs is reducing some of the financial barriers associated with reproductive treatment, contributing to greater participation in the fertility tourism market. Fertility procedures can involve multiple consultations, laboratory services, medications, and treatment cycles, making overall affordability an important consideration when patients compare domestic and international options. Financing programs, installment-based payment structures, and treatment packages can improve access for patients who may otherwise delay or reconsider treatment. When combined with differences in treatment costs across destinations, these financial mechanisms can make cross-border fertility care more feasible for a broader patient population.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising infertility prevalence increasing cross-border demand for IVF and reproductive treatment services | 2.00% | Moderate | Europe, Asia Pacific | High | Near Term |
| Expansion of advanced IVF clinics and ART infrastructure improving international patient accessibility | 1.80% | High | Europe, Asia Pacific | High | Mid Term |
| Growing fertility financing and treatment affordability programs supporting medical travel adoption | 1.40% | Moderate | North America, Asia Pacific | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
Europe (Largest Region)
Europe accounted for the largest share of the fertility tourism market in 2026, supported by established reproductive healthcare infrastructure, availability of specialized fertility services, and cross-border demand for assisted reproductive treatments. Differences in treatment availability, regulatory environments, and access conditions across European countries encourage patients to consider destinations offering suitable procedures and supportive care pathways. Strong medical tourism infrastructure, specialist expertise, and established international patient services further reinforce Europe's attractiveness for fertility-related travel.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is experiencing the fastest growth in the fertility tourism market as fertility awareness increases and reproductive healthcare capabilities continue to expand across the region. Growing demand for assisted reproductive services, improving specialist infrastructure, and rising healthcare expenditure are encouraging patients to explore treatment options beyond their local markets. Expanding medical tourism ecosystems and greater availability of advanced fertility procedures are also strengthening the region's appeal among domestic and international patients seeking accessible reproductive care.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Quality-Centered CareGermany's fertility tourism market is supported by well-established clinical standards and highly specialized reproductive healthcare providers. Germany continues to attract patients seeking reliable treatment quality, although regulatory requirements influence the range of fertility services available to international visitors.
France 🇫🇷
Regulated Clinical ExcellenceFrance supports fertility tourism through specialized reproductive medicine centers operating within a carefully regulated healthcare framework. France remains attractive for patients seeking clinically rigorous treatment, experienced fertility specialists, and comprehensive reproductive health services aligned with established medical standards.
Italy 🇮🇹
Personalized Fertility CareItaly offers fertility tourism through specialized clinics that emphasize individualized treatment plans and patient-centered reproductive care. Italy continues attracting international patients seeking experienced clinicians, advanced IVF procedures, and integrated healthcare services within established fertility centers.
Japan 🇯🇵
Specialized Reproductive ServicesJapan emphasizes technologically advanced fertility treatment supported by experienced specialists and modern clinical infrastructure. International interest in Japan is driven by high-quality reproductive care, particularly among patients seeking advanced laboratory procedures and personalized treatment protocols.
South Korea 🇰🇷
Integrated Medical TravelSouth Korea combines fertility treatment with its established medical tourism ecosystem, offering coordinated patient services and advanced reproductive technologies. South Korea continues strengthening multilingual support, digital patient engagement, and streamlined care pathways for international fertility travelers.
United States 🇺🇸
Advanced Treatment DestinationThe U.S. attracts fertility tourism through specialized reproductive medicine, advanced assisted reproductive technologies, and access to complex treatment options. International patients seek U.S. clinics for individualized care, donor programs, and sophisticated laboratory capabilities that support diverse fertility needs.
Segment Leadership and Growth Trends
Fertility Tourism Market Share (%), by Age Group, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAge Group Segment Analysis: 35-44 (Largest Segment) vs 45-54 (Fastest-Growing Segment)
The 35-44 age group held the largest share of the fertility tourism market at 44.57% in 2026, reflecting the increasing demand for fertility treatments among individuals and couples who may require assisted reproductive services as they pursue parenthood later in life. Patients in this age group may also seek specialized treatment options, broader access to reproductive technologies, and potentially more favorable treatment availability in international destinations. The combination of reproductive planning and access to specialized fertility care supports this group's strong market position.
The 45-54 age group is the fastest-growing segment as advancements in fertility treatment and increasing awareness of available reproductive options encourage older individuals to explore assisted reproductive services. Patients in this age range may seek treatment in destinations offering specialized expertise, advanced reproductive technologies, and broader service availability. Greater awareness of cross-border fertility care is also contributing to the expanding participation of older patients in fertility tourism.
Treatment Segment Analysis: IVF With Own Egg (Largest Segment) vs Donor Egg Treatment (Fastest-Growing Segment)
IVF with own egg accounted for the largest share of the fertility tourism market, reaching 53.49% in 2026. Its leading position is supported by patient preference for treatment using their own genetic material and the established role of IVF in assisted reproduction. International fertility centers offering specialized reproductive services can attract patients seeking access to treatment expertise, advanced laboratory capabilities, and broader care options, supporting continued demand for own-egg IVF.
Donor egg treatment is experiencing the fastest growth as patients facing age-related fertility challenges or reduced ovarian reserve increasingly consider donor-assisted reproductive options. Cross-border treatment can provide access to specialized donor programs and reproductive services that may have varying levels of availability across countries. Greater awareness of donor-assisted conception and expanding acceptance of alternative pathways to parenthood are supporting stronger demand for this treatment segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Age Group | 18-24, 25-34, 35-44, 45-54 | 35-44 | 45-54 |
| Treatment | Donor Egg Treatment, IVF With Own Egg, Surrogacy, Donor Embryo, Sperm Donation | IVF With Own Egg | Donor Egg Treatment |
| Country | U.S., UK, Spain, Czech Republic, Portugal, Thailand, Malaysia, India, South Korea, Turkey | Turkey | Spain |
Competitive Landscape and Market Positioning
Major players in the fertility tourism market:
1. Bumrungrad International Hospital (Thailand)
2. Apollo Fertility (India)
3. Barcelona IVF (Spain)
4. IVF-Life Group (Spain)
5. Alpha IVF & Women’s Specialists (Malaysia)
6. Manchester Fertility Services Ltd. (United Kingdom)
7. San Diego Fertility Center (United States)
8. Eva Fertility Clinics (Cyprus)
9. Genesis IVF Centre (India)
The fertility tourism market is increasingly shaped by integrated healthcare and travel support services designed to improve patient convenience and treatment accessibility. Clinics are adopting teleconsultation platforms, multilingual support systems, and personalized treatment coordination to attract international patients. Competitive differentiation is also being influenced by specialized fertility programs, advanced reproductive technologies, and patient-centric care models.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Bumrungrad International Hospital (Thailand) | |||||||
| Apollo Fertility (India) | |||||||
| Barcelona IVF (Spain) | |||||||
| IVF-Life Group (Spain) | |||||||
| Alpha IVF & Women’s Specialists (Malaysia) | |||||||
| Manchester Fertility Services Ltd. (United Kingdom) | |||||||
| San Diego Fertility Center (United States) | |||||||
| Eva Fertility Clinics (Cyprus) | |||||||
| Genesis IVF Centre (India). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Alpha IVF Group | Jan-26 | Alpha IVF Group began construction of an international-standard fertility center in Bali. This facility is designed to provide high-end reproductive healthcare services tailored for medical tourists, marking a strategic geographic expansion that strengthens Bali’s status as a regional hub for fertility tourism and increases the availability of advanced IVF treatments. |
| First Fertility PGS Center Limited | Jun-25 | First Fertility PGS Center Limited launched a dedicated Indian Lounge in Thailand to facilitate cross-border patient intake. This initiative streamlines the patient experience for those traveling from India for reproductive procedures, reinforcing the company's competitive positioning in the international fertility tourism market through improved concierge and support services. |
| Sabine Hospitals | Jun-24 | Sabine Hospitals secured USD 50 million in a funding round led by CX Partners. This capital infusion is earmarked for expanding clinical service offerings and upgrading operational infrastructure, enhancing the hospital’s capacity to support complex reproductive healthcare procedures and improve patient outcomes in the competitive fertility treatment sector. |
| TMRW Life Sciences | Mar-24 | TMRW Life Sciences introduced CryoLink, a specialized workstation for the digital management of frozen specimen inventories in fertility clinics. By integrating with TMRW’s automated storage solutions and Digital Specimen Management system, this technology enables enhanced laboratory standards and operational efficiency for high-volume fertility treatment providers globally. |
| Birla Fertility & IVF | Aug-23 | Birla Fertility & IVF, part of the CK Birla Group, announced a USD 59.4 million investment plan to scale its presence in the Indian market. The strategy focuses on establishing 10–12 new clinical centers across southern India within a two-year timeframe, significantly increasing its operational footprint and regional capacity for fertility services. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Fertility Tourism Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Healthcare Provider Type | Fertility Clinics, Hospitals, Specialty Reproductive Medicine Centers, Fertility Treatment Networks |
| Payment Model | Self-Pay, Private Insurance, Public Healthcare Coverage, Employer/Third-Party Funding |
| Travel Arrangement Type | Independent Travel, Clinic-Coordinated Travel, Medical Tourism Agency Packages, Integrated Travel-and-Treatment Packages |
Fertility Tourism Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Global Fertility Destination Attractiveness Assessment |
|
| Cross-Border Fertility Patient Journey Assessment |
|
| Patient Acquisition and Referral Channel Strategy |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the fertility tourism market?
What is the projected value of the fertility tourism industry by 2036?
What factors are driving cross-border demand in the fertility tourism market?
How are clinic infrastructure and affordability programs supporting growth in the fertility tourism market?
Why does the 35–44 age group lead the fertility tourism market?
What is driving the growth of Donor Egg Treatment in the fertility tourism market?
Why does Europe lead the fertility tourism market?
What is driving fertility tourism growth in Asia Pacific?
Which companies are driving growth in the fertility tourism landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization